These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33749746)

  • 1. Remdesivir: An Antiviral Still Seeking a Raison d'Être.
    Cummins NW
    Clin Infect Dis; 2021 Nov; 73(10):1857-1859. PubMed ID: 33749746
    [No Abstract]   [Full Text] [Related]  

  • 2. Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases.
    Lo MK; Albariño CG; Perry JK; Chang S; Tchesnokov EP; Guerrero L; Chakrabarti A; Shrivastava-Ranjan P; Chatterjee P; McMullan LK; Martin R; Jordan R; Götte M; Montgomery JM; Nichol ST; Flint M; Porter D; Spiropoulou CF
    Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26946-26954. PubMed ID: 33028676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Remdesivir for patients with severe COVID-19].
    Augustin M; Hallek M; Nitschmann S
    Internist (Berl); 2020 Jun; 61(6):644-645. PubMed ID: 32333086
    [No Abstract]   [Full Text] [Related]  

  • 4. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
    Thalha AMM; Lee YY; Besari A; Omar SFS
    J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
    [No Abstract]   [Full Text] [Related]  

  • 5. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit.
    Sun D
    AAPS J; 2020 May; 22(4):77. PubMed ID: 32458279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncertainty about the Efficacy of Remdesivir on COVID-19.
    Yoo JH
    J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019.
    Igbinosa I; Miller S; Bianco K; Nelson J; Kappagoda S; Blackburn BG; Grant P; Subramanian A; Lyell DJ; El-Sayed YY; Aziz N
    Am J Obstet Gynecol; 2020 Nov; 223(5):768-770. PubMed ID: 32771381
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiviral treatment for COVID-19: the evidence supporting remdesivir.
    Richardson C; Bhagani S; Pollara G
    Clin Med (Lond); 2020 Nov; 20(6):e215-e217. PubMed ID: 32863273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir Use in COVID-19 Patients: Cutaneous Adverse Effect or Disease Manifestation?
    Pulsipher KJ; Presley CL; Szeto MD; Waller JD; Dellavalle RP
    J Drugs Dermatol; 2021 May; 20(5):575. PubMed ID: 33938699
    [No Abstract]   [Full Text] [Related]  

  • 10. Case report study of the first five COVID-19 patients treated with remdesivir in France.
    Dubert M; Visseaux B; Isernia V; Bouadma L; Deconinck L; Patrier J; Wicky PH; Le Pluart D; Kramer L; Rioux C; Le Hingrat Q; Houhou-Fidouh N; Yazdanpanah Y; Ghosn J; Lescure FX
    Int J Infect Dis; 2020 Sep; 98():290-293. PubMed ID: 32619764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement.
    Paladugu S; Donato AA
    Ann Intern Med; 2020 Jul; 173(2):JC4. PubMed ID: 32687756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyanoamidine Cyclization Approach to Remdesivir's Nucleobase.
    Knapp RR; Tona V; Okada T; Sarpong R; Garg NK
    Org Lett; 2020 Nov; 22(21):8430-8435. PubMed ID: 33085486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Audio Interview: New Data on Remdesivir in Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(22):e94. PubMed ID: 32459948
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials.
    Yokoyama Y; Briasoulis A; Takagi H; Kuno T
    Virus Res; 2020 Oct; 288():198137. PubMed ID: 32827627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obsession and Maladaptive Search for Raison D'être: A Condition That May Harm Psychological Wellbeing.
    Akaishi T
    Front Psychol; 2022; 13():845834. PubMed ID: 35719547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Goldilocks Time for Remdesivir - Is Any Indication Just Right?
    Heil EL; Kottilil S
    N Engl J Med; 2022 Jan; 386(4):385-387. PubMed ID: 34936760
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the evidence on remdesivir.
    Núñez I; Soto-Mota A
    Lancet Infect Dis; 2021 Dec; 21(12):1630. PubMed ID: 34838223
    [No Abstract]   [Full Text] [Related]  

  • 18. Does remdesivir have any neuropsychiatric adverse effects?
    Gulati G; Kelly BD
    Ir J Psychol Med; 2021 Dec; 38(4):313-314. PubMed ID: 32641172
    [No Abstract]   [Full Text] [Related]  

  • 19. Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use.
    Boutzoukas AE; Benjamin DK; Zimmerman KO
    Pediatrics; 2021 May; 147(5):. PubMed ID: 33883244
    [No Abstract]   [Full Text] [Related]  

  • 20. Remdesivir Use and Hospital Length of Stay-The Paradox of a Clinical Trial vs Real-Life Use.
    Baracco GJ
    JAMA Netw Open; 2021 Jul; 4(7):e2116057. PubMed ID: 34264333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.